SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010066
Filing Date
2019-11-06
Accepted
2019-11-06 07:09:32
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20190930x10q2c0044.htm   iXBRL 10-Q 2572264
2 EX-10.1 ex-10d1.htm EX-10.1 21401
3 EX-10.2 ex-10d2.htm EX-10.2 20121
4 EX-31.1 ex-31d1.htm EX-31.1 16681
5 EX-31.2 ex-31d2.htm EX-31.2 16710
6 EX-32.1 ex-32d1.htm EX-32.1 15347
7 GRAPHIC vygr-20190930x10q2c0044006.jpg GRAPHIC 61037
  Complete submission text file 0001558370-19-010066.txt   9371994

Data Files

Seq Description Document Type Size
8 EX-101.SCH vygr-20190930.xsd EX-101.SCH 69952
9 EX-101.CAL vygr-20190930_cal.xml EX-101.CAL 53629
10 EX-101.DEF vygr-20190930_def.xml EX-101.DEF 309777
11 EX-101.LAB vygr-20190930_lab.xml EX-101.LAB 550585
12 EX-101.PRE vygr-20190930_pre.xml EX-101.PRE 456752
45 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20190930x10q2c0044_htm.xml XML 1565310
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 191195048
SIC: 2836 Biological Products, (No Diagnostic Substances)